Clinical Trials Directory

Trials / Completed

CompletedNCT01270048

The Effect of Bunsimgieum on the Chest Discomfort of Hwa-byung's Major Symptom

The Effect of Bunsimgi-eum(Fenxinqiyin) on the Chest Discomfort of Hwa-byung's Major Symptom : Randomized, Double-blinded, Placebo-control Trial

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
144 (actual)
Sponsor
Korea Health Industry Development Institute · Other Government
Sex
All
Age
20 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this research is to examine the effect of Bunsimgi-eum on the chest discomfort of Hwa-byung's major symptom and develope and establish pattern identification system in Hwa-byung.

Conditions

Interventions

TypeNameDescription
DRUGmild-ex-gwaripthree times a day, AC 30 min., 4 capsules taken each time (4capsules=2.5g), 8 weeks.
OTHERPlacebothree times a day, AC 30 min., 4 capsules taken each time (4capsules=2.5g), 8 weeks.

Timeline

Start date
2008-05-01
Primary completion
2009-03-01
Completion
2009-08-01
First posted
2011-01-05
Last updated
2011-01-05

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01270048. Inclusion in this directory is not an endorsement.

The Effect of Bunsimgieum on the Chest Discomfort of Hwa-byung's Major Symptom (NCT01270048) · Clinical Trials Directory